Objectives: To assess women's expectations and acceptance of cyclic induced
HRT bleeds before and after their participation in a 1-year study and to c
ompare the impact of these cyclic bleeds with that of previous menstrual bl
eeds. Methods: A structured bleeding questionnaire was used to gather infor
mation: at baseline (before screening) on previous menstrual cycle patterns
and accompanying discomfort, oral contraceptive use, current smoking habit
s, parity and the acceptance, preferences and expectations regarding HRT-in
duced bleeds. Women with amenorrhoea of 6 months or more and FSH levels (35
IU/I then received a daily oral dose of 1 mg 17 beta-oestradiol on days 1-
28, combined with either 5 or 10 mg dydrogesterone on days 15-28, for 12 mo
nths (13 cycles of 28 days). At the end of their participation, women were
again interviewed about their actual experiences with HRT-induced bleeds. R
esults: One hundred and fifty-four women completed the questionnaire at bas
eline and 141 (including 131 completers) responded at the end. At baseline,
82% indicated to be pleased that menstruation had ceased, but nevertheless
94% stated that return of periods would be acceptable. At the end, 91% sti
ll found the occurrence of cyclic bleeds acceptable; this mostly depended o
n the perceived benefits outweighing the discomfort. Of the women who actua
lly experienced bleeds (101) 60% regarded discomfort and blood loss less th
an during their previous menstrual cycles. A regular cycle pattern was cons
idered more important than modest flow and short duration. Conclusions: In
contrast to other studies, the acceptance of renewed vaginal bleeds in our
study was high. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.